CAR-T: Why not me?
On demand

CAR-T: Why not me?

Thursday 08:00 PST / 11:00 EST / 16:00 GMT / 17:00 CET
CAR-T: Why not me?

CAR-T cell immunotherapy treatment has transformed the treatment of some cancers in some patients. But which patient factors determine the success of CAR-T therapies, and how universal is the applicability of CAR-T and its variations such as CAR-NK?

In this webinar, an expert panel will discuss how feasible it is to predict the potential of therapies based on patients’ immunological states, and explore what can be done to adjust CAR-T or other immunotherapies to accommodate those patients.

Attend this webinar for insight into:

  • The applicability of CAR-T and its variations
  • What can be done to adjust CAR-T to accommodate patients who don't meet eligibility criteria
  • How flow cytometry can assist in the research, development and production of these therapies
Nina Senutovitch
Nina Senutovitch
Senior Scientist at Sartorius

Dr Senutovitch received her B.Sc. in biochemistryfrom New Mexico State University. She completed her Ph.D. in biologicalsciences at Carnegie Mellon University, where she developed and detailed thefunction of novel fluorescent probes. 

As a postdoctoral fellow at the University ofPittsburgh, she established biosensor-based live-cell screening assays for thedetection of hepatotoxicity, including the use of a human liver“organ-on-a-chip” model. She joined Sartorius in 2019 as a senior scientist.

Yanping Guo
Yanping Guo
Flow Cytometry Translational Technology Platform Manager at UCL

Yanping is the Flow Cytometry Translational Technology Platform (TTP) manager at the prestigious UCL Cancer Institute. This institute holds an esteemed international reputation for its leadership in diverse realms of cancer research, encompassing fundamental, translational, and clinical dimensions. The Flow Cytometry lab, equipped with the latest equipment, facilitates cutting-edge research that bridges laboratory discoveries to real-world applications.

Yanping gained her D.Phil degree in Clinical Laboratory Sciences from Oxford, backed by a robust background in immunology, haematology, and molecular biology. Her research interests include applying flow and mass cytometry in stem cell and cancer research.

Sarwish Rafiq
Sarwish Rafiq
Assitant Professor at Emory University School of Medicine

Sarwish Rafiq, PhD is an Assistant Professor in the Department of Hematology and Medical Oncology at the Emory School of Medicine. She is a translational scientist with expertise in the preclinical development of immune-based therapies for cancer. Specifically, Dr. Rafiq’s research aims to use mechanistic insight of immune effector cell function against cancer cells in the tumor microenvironment to inform the development of novel and effective cellular therapies.